US big pharma boss doesn’t support tariffs on Australian medicines | 7.30

Key Concepts:

• PBS (Pharmaceutical Benefits Scheme): Australia's government-subsidized medicine program.
• Tariffs: Taxes imposed on imported goods.
• Medication Access: The availability and timely provision of necessary medications to patients.
• Global Standard of Care: Medical treatments or practices widely accepted and used internationally.
• Negotiation Process: The steps and procedures involved in reaching an agreement between parties, in this case, pharmaceutical companies and the Australian government.
• Breakthrough Medication: A new drug that offers significant improvement over existing treatments for a particular condition.

Discussion on Tariffs and the PBS

The speaker addresses the question of whether they are encouraging President Trump to impose tariffs on Australian pharmaceutical exports to the US to pressure the Australian government to change the PBS. The speaker clarifies that while they would like to see changes to the PBS, they do not support tariffs on medications anywhere. They emphasize consistency in opposing such tariffs.

Concerns Regarding the PBS and Medication Access

The speaker highlights concerns about the speed of the PBS process, citing an example of a breakthrough breast cancer medication that took over 600 days and three steps in negotiation to gain access. This medication was the only proven alternative and the global standard of care, yet Australian women with breast cancer had to wait a significant amount of time. The speaker believes this is not a good outcome and attributes the issue to the process itself, which they believe can be improved.

Call for Improvements to the PBS Process

The speaker urges the Australian government to examine how the PBS process can be expedited. The primary complaint is the length of time it takes for medications to become available to patients. The speaker expresses a desire to see changes made to improve the efficiency and timeliness of the PBS.

Notable Quotes:

• "We do not support tariffs on medications anywhere."
• "It's the global standard of care and Australian women who had breast cancer had to wait. I don't think that's a good outcome."
• "It is really about the process which can be fixed."

Synthesis/Conclusion:

The speaker is not advocating for tariffs on Australian pharmaceutical exports. The main concern is the slow and lengthy process of the PBS, which delays access to essential medications for Australian patients. The speaker calls for improvements to the PBS process to ensure timely access to medications, particularly breakthrough treatments that represent the global standard of care.